Nalu Medical, Inc (NALU) Files For up to $100M IPO

Nalu Medical, Inc (NASDAQ: NALU) files for up to $100,000,000M IPO.

The company describes itself as: "We are a medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain. Our currently marketed Nalu neurostimulation system, or Nalu system, delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. We designed our Nalu system to address major unmet needs in the treatment of chronic neuropathic pain and provide a differentiated value proposition for patients and physicians."

J.P. Morgan, BofA Securities and William Blair will serve as underwriters.

You May Also Be Interested In

• CoVolt Power files for proposed IPO
• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders